USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook
USNASALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA’s strategy, including the Company’s initial fiscal year 2026 sales outlook. Preliminary Fiscal Year 2025 Net Sales Results The Company currently anticipates fiscal year 2025 cons
USANA Executive Chairman Kevin Guest Shares Timeless Lessons for a 2026 Growth Mindset
USNASALT LAKE CITY, Jan. 5, 2026 /PRNewswire/ -- As leaders everywhere set sights on the new year, Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA), is encouraging professionals to embrace a growth mindset as the key to lasting achievement and fulfillment. "Success is...
Trust Your Gut--USANA's Probiotic Earns ConsumerLab.com Seal of Approval
USNASALT LAKE CITY, Dec. 16, 2025 /PRNewswire/ -- USANA (NYSE: USNA), the global leader in cellular nutrition, is proud to announce that its top-rated Probiotic supplement has earned the distinguished ConsumerLab.com Seal of Approval. This respected third-party certification recognizes...
USANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven Results
USNA(NYSE:USNA) Breakthrough products and upgrades redefine cellular skincare for radiant, resilient skin SALT LAKE CITY, Sept. 11, 2025 /PRNewswire/ -- USANA (NYSE: USNA), a global leader in cellular nutrition, has unveiled the next evolution of its Celavive skincare brand. The launch includes potent...
Kevin Guest Encourages Self-Improvement as Path to Harmony, Fulfillment
USNA(NYSE:USNA) USANA Health Sciences Executive Chairman Shares Insights for September's Self-Improvement Month SALT LAKE CITY, Sept. 2, 2025 /PRNewswire/ -- In celebration of September's Self-Improvement Month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring...
USANA Introduces New and Upgraded Products, Along with Its Health Professional Advisory Council
USNAAnnounced at USANA's 2025 Global Convention SALT LAKE CITY, Aug. 22, 2025 /PRNewswire/ -- USANA, a global leader in cellular nutrition, recently announced innovative new products, significant ingredient reformulations and upgrades, and refreshed packaging. The company also introduced its...
Usana Health Sciences Q1 Adj. EPS $0.73 Beats $0.71 Estimate, Sales $249.54M Beat $243.04M Estimate
USNAExploring Usana Health Sciences's Earnings Expectations
USNAClinical Study Shows USANA Health's Celavive Resurfacing Serum Enhances Skin Appearance in Just Two Weeks
USNADA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $36
USNAUsana Health Sciences Sees FY2025 GAAP EPS $1.50-$2.20 vs $2.73 Est
USNAUsana Health Sciences Sees FY2025 Adj EPS $2.35-$3.00 vs $2.73 Est; Sees Sales $920.000M-$1.000B vs $934.51M Est
USNAUsana Health Sciences Q4 Adj $0.64 Beats $0.49 Estimate, Sales $213.61M Beat $208.84M Estimate
USNAUSANA Acquires 78.8% Stake In Hiya Health For $205M, Expanding Into Direct-To-Consumer Children's Wellness Market; Deal Expected To Add $103M In Sales And Boost 2025 Adjusted EBITDA Immediately
USNA